Monash University researchers are shedding light on the complex processes that underpin the creation and differentiation of stem cells, bringing closer the promise of ‘miracle’ therapies.
Dr Jose Polo of the Australian Regenerative Medicine Institute (ARMI) and the Department of Anatomy and Developmental Biology and his team, with collaborators at Harvard, have comprehensively mapped, for the first time, the process by which mature cells are re-programmed to become an induced pluripotent stem (iPS) cell.
iPS cells behave almost exactly like embryonic stem cells – they can become any cell in the body – but come without the ethical and scientific pitfalls.
Stem cells are not invincible and therefore not likely to be the magic wand in the world of medicine, but they may be a great clue in finding what will be, a research professor explained on Thursday.
As part of a stem cell seminar series, Barbara Driscoll, Ph. D presented a lecture in the U Building titled “The Impact of Aging on Stem Cells.” The presentation covered basic information about stem cells, the aging process of mammals and how the two are so crucial to the next great discovery in medicine.
Driscoll is an assistant professor of Developmental Biology at USC
A QUT scientist is hoping to unlock the potential of stem cells as a way of repairing neural damage to the brain.
Rachel Okolicsanyi, from the Genomics Research Centre at QUT’s Institute of Health and Biomedical Innovation, said unlike other cells in the body which were able to divide and replicate, once most types of brain cells died, the damage was deemed irreversible.
Ms Okolicsanyi is manipulating adult stem cells from bone marrow to produce a population of cells that can be used to treat brain damage.
“My research is a step in proving that stem cells taken from the bone marrow